Drugs / suprefact
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy3 trials | ||||||
| Phase 1 | NCT02487823 Background | Oct 2014 → Nov 2017 | metastatic prostate carcinoma | Institut Paoli-Calmettes | Terminated | No outcome recorded Stop: Enrollment |
| Phase 3 | NCT01636505 Comparator | Sep 2012 → Feb 2013 | — | European Hospital | Unknown | No outcome recorded |
| Phase 3 | NCT00823602 Comparator | Mar → Oct 2008 | infertility disorder | Yazd Research & Clinical Center for Infertility | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | suprefact | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02487823 ↗ |
| Action | Activate | “GnRH agonist, suprefact” NCT00823602 ↗ |